Cargando…
cGMP signaling: a potential therapeutic target for neurodegeneration in glaucoma?
Autores principales: | Holden, Joseph M., Wareham, Lauren K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838148/ https://www.ncbi.nlm.nih.gov/pubmed/36453407 http://dx.doi.org/10.4103/1673-5374.360169 |
Ejemplares similares
-
cGMP Signaling in the Neurovascular Unit—Implications for Retinal Ganglion Cell Survival in Glaucoma
por: Haider, Ameer A., et al.
Publicado: (2022) -
The CNP/NPR-B/cGMP Axis is a Therapeutic Target in Calcific Aortic Stenosis
por: Armstrong, David W.J., et al.
Publicado: (2021) -
The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies
por: Cai, Zhulan, et al.
Publicado: (2023) -
Dysfunctional cGMP Signaling Leads to Age-Related Retinal Vascular Alterations and Astrocyte Remodeling in Mice
por: Holden, Joseph M., et al.
Publicado: (2022) -
NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009)